Authors: Mary A. Williamson Mt(ascp) Phd,L. Michael Snyder Md
Suggested Reading
Mann SJ, Pickering TG. Detection of renovascular hypertension: State of the art.
Ann Intern Med.
1992;117:845.
PLASMINOGEN
*
Definition
Plasminogen is the inactive, circulating precursor of plasmin, the final product of the fibrinolytic system. Therapy with plasminogen activators results in the generation of plasmin and intended thrombolysis.
Normal range:
70–113%.
Interpretation
Decreased In
Congenital: rare reported cases; may result in a predisposition to thrombosis
Acquired: severe DIC, pathologic fibrinolysis, or as the result of thrombolytic therapy, and in liver disease
PLASMINOGEN ACTIVATOR INHIBITOR 1 (PAI 1)
*
Definition
PAI 1, an inhibitor of plasminogen activation is synthesized in endothelial cells, in platelets, and by the liver.
Normal range:
0.0–22.0 IU/mL.
Use
This test may be used in rare cases with a tendency to thrombosis when no other cause is identified.
Interpretation
Decreased Values
Difficult to determine because the normal range can be as low as 0.0